| Loyal Shane Farley, DO | |
|
950 E Bogard Rd Ste 103, Wasilla, AK 99654-7184 | |
| (907) 352-2880 | |
| Not Available |
| Full Name | Loyal Shane Farley |
|---|---|
| Gender | Male |
| Speciality | General Practice |
| Location | 950 E Bogard Rd Ste 103, Wasilla, Alaska |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659930006 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 192430 (Alaska) | Secondary |
| 208D00000X | General Practice | 192430 (Alaska) | Primary |
| Entity Name | Mat Su Valley Medical Center Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912950148 PECOS PAC ID: 5698686475 Enrollment ID: O20040123000583 |
News Archive
Millions of Americans suffer from severe addictions that can ruin lives and are extremely difficult to control. Nearly 2 million enter roughly 12,000 addiction treatment programs in the U.S. each year.
Students who received eyeglasses through a school-based program scored higher on reading and math tests, Johns Hopkins researchers from the Wilmer Eye Institute and School of Education found in the largest clinical study of the impact of glasses on education ever conducted in the United States.
GTx, Inc. today provided a Company update and reported financial results for the second quarter of 2012.
Phase Forward, a leading provider of data management solutions for clinical trials and drug safety, today announced a multi-year contract with renowned eye health company Bausch & Lomb. The agreement calls for Bausch & Lomb to implement Phase Forward's InForm™ Global Trial Management (GTM) electronic data capture (EDC) solution, including the Central Coding™ module, in all of its trials, including Surgical, Vision Care and Pharmaceuticals products.
› Verified 8 days ago
| Entity Name | Matsu Emergency Medicine Physicians Corp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073548129 PECOS PAC ID: 1557251022 Enrollment ID: O20040318000130 |
News Archive
Millions of Americans suffer from severe addictions that can ruin lives and are extremely difficult to control. Nearly 2 million enter roughly 12,000 addiction treatment programs in the U.S. each year.
Students who received eyeglasses through a school-based program scored higher on reading and math tests, Johns Hopkins researchers from the Wilmer Eye Institute and School of Education found in the largest clinical study of the impact of glasses on education ever conducted in the United States.
GTx, Inc. today provided a Company update and reported financial results for the second quarter of 2012.
Phase Forward, a leading provider of data management solutions for clinical trials and drug safety, today announced a multi-year contract with renowned eye health company Bausch & Lomb. The agreement calls for Bausch & Lomb to implement Phase Forward's InForm™ Global Trial Management (GTM) electronic data capture (EDC) solution, including the Central Coding™ module, in all of its trials, including Surgical, Vision Care and Pharmaceuticals products.
› Verified 8 days ago
| Entity Name | Mat-su Valley Iii Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366752560 PECOS PAC ID: 5496941502 Enrollment ID: O20101130001385 |
News Archive
Millions of Americans suffer from severe addictions that can ruin lives and are extremely difficult to control. Nearly 2 million enter roughly 12,000 addiction treatment programs in the U.S. each year.
Students who received eyeglasses through a school-based program scored higher on reading and math tests, Johns Hopkins researchers from the Wilmer Eye Institute and School of Education found in the largest clinical study of the impact of glasses on education ever conducted in the United States.
GTx, Inc. today provided a Company update and reported financial results for the second quarter of 2012.
Phase Forward, a leading provider of data management solutions for clinical trials and drug safety, today announced a multi-year contract with renowned eye health company Bausch & Lomb. The agreement calls for Bausch & Lomb to implement Phase Forward's InForm™ Global Trial Management (GTM) electronic data capture (EDC) solution, including the Central Coding™ module, in all of its trials, including Surgical, Vision Care and Pharmaceuticals products.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Loyal Shane Farley, DO 307 Grizzly Trl, Harker Heights, TX 76548-5628 Ph: () - | Loyal Shane Farley, DO 950 E Bogard Rd Ste 103, Wasilla, AK 99654-7184 Ph: (907) 352-2880 |
News Archive
Millions of Americans suffer from severe addictions that can ruin lives and are extremely difficult to control. Nearly 2 million enter roughly 12,000 addiction treatment programs in the U.S. each year.
Students who received eyeglasses through a school-based program scored higher on reading and math tests, Johns Hopkins researchers from the Wilmer Eye Institute and School of Education found in the largest clinical study of the impact of glasses on education ever conducted in the United States.
GTx, Inc. today provided a Company update and reported financial results for the second quarter of 2012.
Phase Forward, a leading provider of data management solutions for clinical trials and drug safety, today announced a multi-year contract with renowned eye health company Bausch & Lomb. The agreement calls for Bausch & Lomb to implement Phase Forward's InForm™ Global Trial Management (GTM) electronic data capture (EDC) solution, including the Central Coding™ module, in all of its trials, including Surgical, Vision Care and Pharmaceuticals products.
› Verified 8 days ago